CYTEK BIOSCIENCES, INC. Inventory Write-down
CYTEK BIOSCIENCES, INC. (CTKB) reported Inventory Write-down of $633.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. inventory write-down for the quarter ending 2026-06-30 was $440.00K, a 1995.24% increase year-over-year.
- CYTEK BIOSCIENCES, INC. inventory write-down for the quarter ending 2026-03-31 was $193.00K, a 38.54% decline year-over-year.
- CYTEK BIOSCIENCES, INC. inventory write-down for the quarter ending 2025-12-31 was $1.24M, a 361.19% increase year-over-year.
- CYTEK BIOSCIENCES, INC. inventory write-down for the quarter ending 2025-09-30 was $132.00K, a 61.29% decline year-over-year.
- CYTEK BIOSCIENCES, INC. inventory write-down for fiscal 2025 was $1.70M, a 3.46% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. inventory write-down for fiscal 2024 was $1.65M, a 12.13% increase from fiscal 2023.
- CYTEK BIOSCIENCES, INC. inventory write-down for fiscal 2023 was $1.47M, a 94.18% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. inventory write-down for fiscal 2022 was $756.00K, a 54.92% increase from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $633.00K 10-Q · filed 2026-08-05 | $1.87M derived: sum of 3 quarters · filed 2026-08-05 | $2.00M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $193.00K 10-Q · filed 2026-05-07 | $1.43M derived: sum of 2 quarters · filed 2026-05-07 | $1.56M derived: sum of 3 quarters · filed 2026-05-07 | $1.58M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.37M derived: sum of 2 quarters · filed 2026-02-26 | $1.39M derived: sum of 3 quarters · filed 2026-08-05 | $1.70M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $153.00K derived: sum of 2 quarters · filed 2026-08-05 | $467.00K 10-Q · filed 2025-11-05 | $735.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $335.00K 10-Q · filed 2026-08-05 | $603.00K derived: sum of 3 quarters · filed 2026-08-05 | $944.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $314.00K 10-Q · filed 2026-05-07 | $582.00K derived: sum of 2 quarters · filed 2026-05-07 | $923.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.05M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $609.00K derived: sum of 2 quarters · filed 2026-02-26 | $734.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.65M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $466.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.38M 10-Q · filed 2025-11-05 | $2.05M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.04M 10-Q · filed 2025-08-06 | $1.71M derived: sum of 3 quarters · filed 2026-02-26 | $1.91M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $912.00K 10-Q · filed 2025-05-08 | $1.58M derived: sum of 2 quarters · filed 2026-02-26 | $1.78M derived: sum of 3 quarters · filed 2026-02-26 | $1.87M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $872.00K derived: sum of 2 quarters · filed 2026-02-26 | $960.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.47M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $290.00K derived: sum of 2 quarters · filed 2024-11-07 | $798.00K 10-Q · filed 2024-11-07 | $1.09M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $596.00K 10-Q · filed 2024-08-06 | $890.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.06M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $508.00K 10-Q · filed 2024-05-08 | $802.00K derived: sum of 2 quarters · filed 2025-02-28 | $977.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.19M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $469.00K derived: sum of 2 quarters · filed 2025-02-28 | $682.00K derived: sum of 3 quarters · filed 2025-02-28 | $756.00K 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $388.00K derived: sum of 2 quarters · filed 2023-11-14 | $462.00K 10-Q · filed 2023-11-14 | $617.00K derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-06-30 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $287.00K 10-Q · filed 2023-08-08 | $442.00K derived: sum of 3 quarters · filed 2024-03-13 | $512.00K derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-03-31 | $74.00K 10-Q · filed 2023-05-09 | -$74.00K 10-Q · filed 2022-05-12 | $229.00K derived: sum of 2 quarters · filed 2024-03-13 | $299.00K derived: sum of 3 quarters · filed 2024-03-13 | $241.00K derived: sum of 4 quarters · filed 2024-03-13 | |
| 2021-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $225.00K derived: sum of 2 quarters · filed 2024-03-13 | $167.00K derived: sum of 3 quarters · filed 2024-03-13 | $488.00K 10-K · filed 2024-03-13 | ||
| 2021-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $12.00K derived: sum of 2 quarters · filed 2022-11-09 | $333.00K 10-Q · filed 2022-11-09 | -$333.00K 10-Q · filed 2021-11-12 | $703.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $263.00K 10-Q · filed 2022-08-10 | $633.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.03M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $321.00K 10-Q · filed 2022-05-12 | $691.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.09M derived: sum of 3 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $370.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $772.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.57M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.20M 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $797.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |